GENWORTH FINANCIAL INC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001276520
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2023 · 4 positions · Total reported value $316.20M · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 0.0% · 0 new · 0 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2023 13F filing, GENWORTH FINANCIAL INC disclosed 4 equity positions with a combined reported value of $316.20M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Buy & Hold.
The largest disclosed positions as of Q4 2023 were IVV ($287.28M), SPLV ($28.53M), MIRM ($385.27K). By sector, the heaviest allocations are Health Care 0.1%, Other 99.9%.
Versus the prior quarter, GENWORTH FINANCIAL INC opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 50% of names.
The largest new positions opened in Q4 2023 were MIRM ($385.27K), UDMY ($1.92K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2023)
- MIRM MIRUM PHARMACEUTICALS INC · $385.27K
- UDMY UDEMY INC · $1.92K
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest GENWORTH FINANCIAL INC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Genworth Financial is an SEC-registered 13F filer. As of Q2 2026 it reported 2 US equity positions with a combined value of $486.12M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 2 positions · $486.12M reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: IVV (ISHARES TR) at 92.7%
- Average position size: $243.06M
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
FAQ
What did GENWORTH FINANCIAL INC buy in 2023-Q4?
In its 2023-Q4 13F filing, GENWORTH FINANCIAL INC reported 4 equity positions worth $316.20M in aggregate; its largest disclosed positions were IVV ($287.28M), SPLV ($28.53M), MIRM ($385.27K).
How large is GENWORTH FINANCIAL INC's portfolio?
GENWORTH FINANCIAL INC reported $316.20M of long equity holdings across 4 positions as of 2023-Q4. Top-10 holdings account for 100.0% of reported value.
What is GENWORTH FINANCIAL INC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Buy & Hold, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.